Covered recipient · General Payments record
JOHN S TIDBALL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018
$171.53
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $171.53 | 8 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $61.28 | 1 |
| Acerta Pharma LLC | $33.36 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30.75 | 2 |
| Novo Nordisk AS | $19.28 | 1 |
| Seqirus USA Inc | $16.08 | 1 |
| Lilly USA, LLC | $10.78 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $171.53 | 8 |
Payment records · PY2018 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $17.27 | 03/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 561093661 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.09 | 03/27/2018 | Food and Beverage | Undisputed | 01/23/2026 | 560563137 | CMS |
| GlaxoSmithKline, LLC. | $61.28 | 02/02/2018 | Food and Beverage | Undisputed | 01/23/2026 | 593589195 | CMS |
| Lilly USA, LLC | $10.78 | 03/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | 559390299 | CMS |
| Novo Nordisk Inc | $19.28 | 02/22/2018 | Food and Beverage | Undisputed | 01/23/2026 | 588875711 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.11 | 02/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | 589719941 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.64 | 04/10/2018 | Food and Beverage | Undisputed | 01/23/2026 | 589719947 | CMS |
| Seqirus USA Inc | $16.08 | 01/11/2018 | Food and Beverage | Undisputed | 01/23/2026 | 601331193 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.